Roc vs. Sux - The CURASMUR Trial

February 18, 2020 00:19:11
Roc vs. Sux - The CURASMUR Trial
Critical Care Perspectives in Emergency Medicine
Roc vs. Sux - The CURASMUR Trial

Feb 18 2020 | 00:19:11

/

Show Notes

The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial comparing rocuronium with succinylcholine in out-of-hospital patients needing emergency tracheal intubation – The CURASMUR Trial. Emergency medicine airway guru Dr. Ken Butler takes us through the paper and provides his expert opinion on which NMBA you should be reaching for in your next intubation!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

March 04, 2019 00:28:51
Episode Cover

Troubleshooting the Trach

Respiratory distress in the patient with a tracheostomy can incite fear in even the most seasoned emergency physician or intensivist.  In this episode, we...

Listen

Episode 0

February 09, 2023 00:25:24
Episode Cover

Should We Use a Liberal or Restrictive Fluid Strategy in Sepsis - The CLOVERS Trial

Intravenous fluid (IVF) administration is a central tenet to the resuscitation of patients with sepsis and sepsis-induced hypotension.  At present, the administration of large...

Listen

Episode

November 01, 2024 00:22:22
Episode Cover

Naloxone for OHCA?

The incidence of opioid-associated out-of-hospital cardiac arrests continues to rise.  Current guidelines for the resuscitation of patients with OHCA advise the clinician to consider...

Listen